Research & Scientific Literature

Reported findings

Among 20 evaluated participants, none of these outcomes changed significantly (p > 0.05), despite reported satisfaction in some participants.

Limitations

• Twenty of the original 40 participants were excluded; no concurrent placebo group.
• Non-CF bronchiectasis and a salt-crystal inhaler should not be generalized to cystic fibrosis or powered salt-room systems.

Reported findings

The authors reported changes in flow-volume lung-function measures and blood pressure.

Limitations

• Older Russian-language publication; the indexed English abstract provides limited information about allocation, controls and long-term follow-up.
• The historical grouping includes asthma and chronic bronchitis, not necessarily patients meeting current COPD definitions.

Reported findings

The authors reported changes in inflammatory, immune and clinical indicators in the treated participants.

Limitations

• Very small, unequal groups and mixed diagnoses.
• Controls received home medication; treatment-setting and concurrent-care differences make causal conclusions uncertain.

Reported findings

The authors describe favorable symptoms and lung-function changes in several diagnosis groups.

Limitations

• Small, unequal comparison groups and mixed diagnoses; allocation and selection raise concerns.
• This historical study does not establish outcomes for a specific modern product.

Verification note

The source PDF and Crossref record identify a 1995 publication, not the supplied 2000 date. DOI: 10.1089/jam.1995.8.221. The supplied original-paper PDF remains available.

Reported findings

The authors reported faster changes in some short-term respiratory-failure measures with adjunctive salt inhalation.

Limitations

• Retrospective, nonrandomized comparison with concurrent medication and oxygen.
• Emergency-care mask delivery is not equivalent to a wellness salt-room session.

Reported findings

The authors report changes in the control pause and propose further investigation. This is not a trial demonstrating treatment of respiratory disease.

Limitations

• Very small, short-term investigation in healthy participants using a surrogate measure.
• Discussion of two approaches does not isolate or establish the effectiveness of a combined treatment.

Verification note

The supplied PDF carries a May 2017 volume 6/issue 5 header as well as conflicting legacy template text mentioning November 2014. An independent journal article record was not located.

Reported findings

Bronchial hyperresponsiveness decreased more in the active group. Baseline FEV₁ and peak expiratory flow did not change.

Limitations

• Small, two-week add-on study; it does not establish long-term asthma control.
• Medication continued during the trial, so results do not support halotherapy as a replacement.

Reported findings

The authors discuss potential adjunctive benefits but request larger evidence-based studies. Much of the reviewed literature concerns wet hypertonic saline or diagnostic procedures, rather than dry salt-room treatment.

Limitations

• Diagnostic bronchial challenge tests are not therapeutic trials.
• Wet saline, speleotherapy and dry salt aerosol are distinct interventions and their results are not interchangeable.

Reported findings

Airway hyperreactivity decreased in some participants, but was unchanged or increased in others; responses differed by challenge type.

Limitations

• Small sample without a described placebo comparison.
• Provocation-test changes should not be treated as established long-term symptom control.

Reported findings

Changes in lung function and inflammatory markers were accompanied by reduced activity in NLRP3-related signaling pathways in treated rats.

Limitations

• Animal research only—not a clinical trial and not evidence of effectiveness in humans.
• An induced rat disease model and experimental exposures cannot establish outcomes with consumer equipment.

Verification note

Published December 2022 and indexed in 2023. The publisher PDF and PMID 36618788 refer to one publication.

Reported findings

Walking distance and respiratory quality-of-life scores improved within the salt-room group. Its FEV₁ change was not statistically significant; some measures also improved in comparison groups.

Limitations

• Small pilot with different interventions and within-group comparisons.
• Within-group changes alone do not establish superiority over controls; wet saline and dry chamber exposure are not equivalent.

Reported findings

The abstract describes favorable clinical and laboratory changes after dry salt aerosol exposure.

Limitations

• Older Russian-language publication; the indexed English abstract provides limited information about allocation, controls and long-term follow-up.
• A small rehabilitation series cannot establish causation or a reproducible treatment effect.

Reported findings

The abstract reports improvement in symptoms, ventilatory measures and exercise tolerance during the combined program.

Limitations

• Older Russian-language publication; the indexed English abstract provides limited information about allocation, controls and long-term follow-up.
• Multiple treatments were used; reported improvements cannot be attributed entirely to halotherapy.

Reported findings

The abstract describes changes in oxidative measures, local immune indicators and the clinical course.

Limitations

• Older Russian-language publication; the indexed English abstract provides limited information about allocation, controls and long-term follow-up.
• Laboratory-marker changes are not equivalent to proven improvements in long-term health.
• The same authors' other 2000 report also describes 49 patients; possible participant overlap is not resolved by the abstracts. They are distinct publications, not necessarily independent cohorts.

Reported findings

The authors report correction of certain oxidative disturbances and an improved clinical course when halotherapy was added.

Limitations

• Older Russian-language publication; the indexed English abstract provides limited information about allocation, controls and long-term follow-up.
• Combined treatment prevents attributing all reported changes to salt aerosol.
• Possible cohort overlap with the authors' other 2000 chronic-bronchitis report remains unclear.

Reported findings

The abstract describes favorable inflammatory and drainage-related observations and follow-up assessments extending to twelve months.

Limitations

• Older Russian-language publication; the indexed English abstract provides limited information about allocation, controls and long-term follow-up.
• The abstract does not establish a reliable controlled effect size for infection prevention.

Reported findings

The primary reduction in adenoid/tonsil enlargement was not statistically significant (p = 0.204). Some secondary hearing and middle-ear pressure outcomes favored the active arm.

Limitations

• Small trial with a nonsignificant primary endpoint.
• Secondary outcomes need cautious interpretation and independent confirmation.

Reported findings

The authors report that the integrated approach produced more favorable clinical and nasal-function observations than either method separately.

Limitations

• Combined treatment findings cannot be assigned solely to halotherapy.
• Older Russian-language publication; the indexed English abstract provides limited information about allocation, controls and long-term follow-up.

Reported findings

Sinus symptom scores and some quality-of-life domains improved. FEV₁ and FVC did not change significantly; the dyspnea change also did not reach significance.

Limitations

• Very small uncontrolled pilot; expectation and concurrent-care effects cannot be separated.
• Results do not establish long-term pulmonary benefit or replace established cystic-fibrosis care.

Reported findings

The author describes observations in dermatitis, psoriasis and other skin conditions; the accessible paper does not present a clearly controlled efficacy trial.

Limitations

• Sample sizes, controls and methods are insufficiently detailed to support reliable effect estimates.
• Skin mechanisms and reported responses cannot establish product effectiveness.

Verification note

The translated PDF identifies the original 2006 issue 3(36), pages 74–75. The original-language journal record was not independently located.

Reported findings

The authors discuss favorable observations in earlier publications while emphasizing limited scientific evidence and the need for larger, longer-term studies.

Limitations

• Different salt interventions and populations are discussed together.
• The article does not provide controlled proof of skin benefits or a universal safety guarantee.

Verification note

Published online November 24, 2022, in volume 13(1), a 2023 issue; both dates are retained to avoid ambiguity.

Reported findings

The authors describe favorable changes in respiratory volumes and several effort-test observations after the program.

Limitations

• Small study with limited reporting of randomization and blinding.
• Training and recovery effects are difficult to separate from exposure; this does not establish improved competitive performance.

Verification note

DOI 10.1016/j.sbspro.2012.06.214 is present in the original paper. The supplied full-paper PDF is retained where publisher access is restricted.

Reported findings

The authors reported more favorable outcomes for combined physical-therapy approaches. Participants also received exercise and chest massage.

Limitations

• Several concurrent interventions make a halotherapy-specific effect uncertain.
• Older Russian-language publication; the indexed English abstract provides limited information about allocation, controls and long-term follow-up.

Verification note

The indexed English title contains apparent translation errors (“combed” and “patient”); the card retains the indexed bibliographic title.

Reported findings

The author reported differences in cough/sputum observations and selected pharyngeal microbial and immune measures.

Limitations

• Small, short-term conference report; complete trial-reporting and allocation details are limited.
• No evidence that salt inhalation offsets smoking harms or prevents COPD.

Verification note

The supplied report identifies ERS 2006, volume 28, supplement 50, pages 106s–107s. An independent original conference record was not located.

Reported findings

The paper proposes further investigation; it does not report a halotherapy trial in people with COVID-19.

Limitations

• Hypothesis-generating discussion, not evidence of prevention or treatment of COVID-19.
• Findings in other respiratory conditions cannot be assumed to apply to COVID-19.

Reported findings

The report describes fewer recorded respiratory illness episodes and symptom days in the salt-inhalation group.

Limitations

• Conference poster, not a fully reported independent long-term trial; ascertainment and allocation details are limited.
• This does not establish prevention of a specific infection, including COVID-19, or outcomes using HaloTherapyPRO.

Verification note

The supplied poster identifies the 2009 ERS meeting, volume 34, supplement 53, page 401s. An independently accessible original congress record was not located.

Reported findings

Respondents reported perceived improvements in respiratory complaints, skin condition, relaxation and sleep. These are self-reported observations, not proof of a treatment effect.

Limitations

• No randomized comparator; selection, expectation and reporting biases may affect the results.
• A system-specific satisfaction survey cannot establish efficacy or predict outcomes with HaloTherapyPRO.

Verification note

Published online in 2024, with a 2025 journal issue. Added as recent observational research, not as a controlled clinical trial.

Reported findings

The article presents proposed biophysical mechanisms, equipment characteristics and clinical rationales; it does not report a new randomized comparison.

Limitations

• Historical narrative discussion, not a pooled systematic review.
• Proposed mechanisms and clinical rationale do not establish effectiveness.

Reported findings

Many session users reported feeling better. The study describes preferences and perceived well-being rather than controlled disease outcomes.

Limitations

• Self-reported survey without randomized allocation or objective efficacy measurements.
• Participants who choose salt-cave sessions may differ from nonusers.

Reported findings

The article brings together proposed mechanisms and earlier clinical observations, not a new independent randomized trial.

Limitations

• Narrative selection of earlier evidence without a systematic risk-of-bias analysis.
• Differences in chambers, concentrations and protocols limit generalization.

Reported findings

The article describes preliminary observations, including sinus complaints in cystic fibrosis, and distinguishes dry salt aerosol from nebulized hypertonic saline.

Limitations

• Expert commentary, not a peer-reviewed clinical trial or systematic review.
• The author discloses advisory roles with a salt room and the Salt Therapy Association; independent confirmation remains important.

Verification note

The scanned page was visually verified: Florida MD, July 2015, page 10. It is labeled as commentary rather than clinical trial evidence.

Reported findings

The authors describe favorable findings in several lung-function and quality-of-life measures, while calling for more structured randomized trials and noting the absence of official salt-room or dry-inhaler guidelines.

Limitations

• Different interventions and study populations were combined in a narrative discussion, not a pooled effectiveness estimate.
• The review does not show that every study or every measured outcome improved.

Verification note

The indexed title ends “From the Cave to the Clinical.” Published in the March 2022 issue; initially available online in 2020. This corrects the previous listing's shortened title and date.

Reported findings

The author presents potential mucus-clearance, airway and skin effects drawn from earlier literature, rather than a new controlled trial.

Limitations

• Narrative review; the English abstract does not provide a formal evidence-quality assessment.
• Protocol descriptions are not product-use instructions or proof of effectiveness.

Reported findings

The authors discuss potential complementary uses across respiratory conditions. The publication does not establish efficacy for mold-related illness through a new controlled trial.

Limitations

• Combines different salt exposures, including wet saline methods and cave environments.
• Mechanistic proposals and narrative recommendations are not device-specific clinical evidence.

Reported findings

The authors describe historical experience and potential mechanisms. This is background literature, not a modern controlled efficacy study.

Limitations

• Older narrative article; many cited studies predate contemporary trial-reporting standards.
• The accessible translated copy does not independently resolve every detail of the original Russian publication.

Verification note

Journal, year and pages (3:82–88) are corroborated in later scholarly references. An independent original-journal landing page was not located; the translated original article is retained.

Reported findings

The review describes clinical experience and differentiates active aerosol generation from decorative salt surfaces.

Limitations

• Not a newly randomized clinical investigation or a pooled systematic analysis.
• The translated copy provides limited independent verification of the original-language journal record.

Verification note

The accessible translation identifies 2003, issue 6, pages 8–15; a matching independent original-journal landing page was not located.

Reported findings

The article offers a narrative account of potential uses rather than a new controlled demonstration of respiratory benefit.

Limitations

• Narrative review without a pooled estimate or formal evidence-quality grading.
• Historical mechanisms and clinical recommendations do not establish effectiveness.

Reported findings

The paper discusses potential respiratory and skin applications alongside practical cautions; it is not a new efficacy or safety trial.

Limitations

• No systematic pooled analysis or independent estimate of adverse-event frequency.
• Descriptions of tolerability do not mean an intervention is appropriate for every person or condition.

Reported findings

The authors discuss potential adjunctive effects but explicitly acknowledge that scientific evidence is limited and higher-quality research is required.

Limitations

• Narrative synthesis, not a new treatment trial or robust pooled effectiveness analysis.
• Absence of reported serious events in selected papers is not proof of universal safety.

Reported findings

Responses varied with the aerosol formulation. One sodium chloride exposure increased ciliary activity, tracheal mucus velocity and bronchial clearance, while another sodium chloride exposure reduced bronchial clearance. The findings were not uniformly favorable.

Limitations

• Liquid saline aerosols are not the same intervention as dry salt aerosol from a halogenerator.
• Laboratory airway measurements do not establish clinical benefits, disease treatment or safety of consumer dry-salt equipment for dogs.
• Experimental concentrations and exposure methods must not be used as home-session or veterinary dosing recommendations.

Verification note

Canine preclinical research using liquid aerosols, not a dry-room halotherapy trial and not research on HaloTherapyPRO equipment.